BioMérieux Unveils SMARTBIOME, a DNA-Based Solution to Combat Food Spoilage
French company bioMérieux announced on February 18, 2026, the launch of SMARTBIOME, a solution aimed at the agri-food industry to better understand and prevent microbiological spoilage. This platform combines DNA sequencing, bioinformatics, and microbiological expertise to enhance product quality and reduce food loss.
The Challenge of Microbiological Spoilage in the Food Industry
Microbiological spoilage is a significant challenge for the food industry. Microorganisms such as Pseudomonas bacteria, spore-forming bacteria, or certain molds can degrade fresh and processed products, leading to waste and economic losses. According to a scientific review published in Nature Reviews Microbiology (Snyder, Martin & Wiedmann, 2024), 15 to 20% of food produced worldwide is discarded, partly due to microbial deterioration phenomena. SMARTBIOME aims to precisely identify these spoilage floras and understand their origins.
Integrating High-Resolution Genomic Sequencing and Data Analysis
Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
✓ Before 9 AM every morning✓ Euronext data✓ AI-powered analysis
You're in — subscription confirmed!
Your first edition is on its way. Check your spam folder and add us to your contacts.
An error occurred.
Indicative data. No investment advice. Unsubscribe at any time.
Gratuit · chaque matin
Ne ratez plus rien sur vos actions
La tendance derrière les cours. L'essentiel des valeurs Euronext en quelques minutes.
📈les valeurs en mouvement, sur la durée
🎯les objectifs d'analystes qui évoluent
📰les actualités qui font bouger les cours
tendance · 6 séances
✓ C'est fait, vous êtes inscrit !
Votre première édition arrive bientôt. Pensez à vérifier vos spams.
Une erreur est survenue.
CAC 40 · SBF 120 · données indicatives · aucun conseil en investissement · désinscription à tout moment.
The solution combines high-resolution genomic sequencing, data analysis, and a specialized knowledge base to transform complex microbiological data into actionable information. Developed in collaboration with Brazilian company Neoprospecta, acquired by bioMérieux in January 2025, it enables the tracking of microbiological evolution over time, anticipation of contaminations, and adjustment of production processes. SMARTBIOME is already available in Europe, North America, and Latin America.
SectorDiagnostic et services de laboratoire›Diagnostic / labos d'analyse
Free · every morning · before 9am
Never miss a move on your stocks
The trend behind the prices · Euronext
✓ You're in! Check your spam folder.
An error occurred.
Context
Period
Period: S1 2026
Key reported figures
Revenue: 1 965 millions d'euros
Quarterly revenue: 1 965 millions d'euros
Revenue growth: -3,9 %
EBITDA: 440,3 millions d'euros
EBITDA margin: 22,4 %
Net income: 226,1 millions d'euros
Free cash flow: 299 millions d'euros
-235,9 millions d'euros
Guidance from the release
confirme ses perspectives pour 2026 : croissance organique du chiffre d'affaires comprise entre +3% et +5%, CEBIT croissance comprise entre 0% et +10%
Risks mentioned
Épidémiologie respiratoire plus faible : recul organique de 17 % des panels respiratoires BIOFIRE®
Effet de change défavorable de 35 M€ sur le ROCC du premier semestre 2026
Environnement géopolitique et macroéconomique dégradé depuis 2024
Opportunities identified
Croissance organique de 6 % des quatre moteurs de croissance du plan GO•28
Dépôt auprès de la FDA du panel SPOTFIRE® Vaginitis
Obtention du marquage CE du premier test SPINCHIP®
The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.
Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.
